【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 8
1.1 List of Tables 15
1.2 List of Figures 20
2 Introduction 21
2.1 Catalyst 21
2.2 Upcoming Related Reports 22
3 Disease Overview 23
3.1 Classification of Seizures 25
3.2 Etiology and Pathophysiology 26
3.2.1 Etiology 26
3.2.2 Pathophysiology 29
3.2.3 Prognosis 34
3.2.4 Quality of Life 35
4 Epidemiology 36
4.1 Risk Factors and Comorbidities 36
4.1.1 Risk factors in newborns often include brain malformations and lack of oxygen 36
4.1.2 Genetic factors and head trauma are risk factors in adults and children 36
4.1.3 Common seizure triggers include lack of sleep, stress, and photosensitivity 37
4.1.4 Epilepsy comorbidities in adults and children include pain disorders 37
4.1.5 Anxiety and depression are major epilepsy comorbidities 37
4.1.6 Epilepsy with a known cause can be prevented by the avoidance of head injuries 38
4.2 Global Trends 38
4.2.1 United States 39
4.2.2 5EU Markets (France, Germany, Italy, Spain, and the UK) 40
4.2.3 Asia 41
4.3 Forecast Methodology 43
4.3.1 Sources Used 44
4.3.2 Forecast Assumptions and Methods 49
4.3.3 Sources Not Used 51
4.4 Epidemiologic Forecast 52
4.4.1 Total Active Prevalent Cases of Epilepsy 52
4.4.2 Total Lifetime Prevalent Cases of Epilepsy 54
4.4.3 Age-Specific Total Active Prevalent Cases of Epilepsy 56
4.4.4 Gender-Specific Total Active Prevalent Cases of Epilepsy 57
4.4.5 Seizure-Specific Total Active Prevalent Cases of Epilepsy 58
4.5 Discussion 59
4.5.1 Conclusion on Epidemiological Trends 59
4.5.2 Limitations of the Analysis 60
4.5.3 Strengths of the Analysis 60
5 Disease Management 61
5.1 Diagnosis 61
5.2 Treatment Guidelines 62
5.3 Clinical Practice 63
5.4 US 69
5.4.1 Diagnosis 69
5.4.2 Clinical Practice 71
5.5 UK 74
5.5.1 Diagnosis 74
5.5.2 Clinical Practice 75
5.6 France 76
5.6.1 Diagnosis 76
5.6.2 Clinical Practice 77
5.7 Germany 78
5.7.1 Diagnosis 78
5.7.2 Clinical Practice 79
5.8 Spain 81
5.8.1 Diagnosis 81
5.8.2 Clinical Practice 82
5.9 Italy 83
5.9.1 Diagnosis 83
5.9.2 Clinical Practice 84
5.10 Japan 85
5.10.1 Diagnosis 85
5.10.2 Clinical Practice 86
5.11 India 87
5.11.1 Diagnosis 87
5.11.2 Clinical Practice 87
5.12 China 89
5.12.1 Diagnosis 89
5.12.2 Clinical Practice 91
6 Competitive Assessment 93
6.1 Overview 93
6.2 Strategic Competitor Assessment 94
6.3 Product Profiles – Major Brands 97
6.3.1 Keppra (levetiracetam) 97
6.3.2 Lamictal (lamotrigine) 102
6.3.3 Lyrica (pregabalin) 107
6.3.4 Vimpat (lacosamide) 111
6.3.5 Zonegran (zonisamide) 115
6.3.6 Banzel/Inovelon (rufinamide) 120
6.3.7 Trobalt/Potiga (retigabine/ezogabine) 124
6.3.8 Zebinix (eslicarbazepine acetate) 127
6.3.9 Fycompa (perampanel) 131
6.3.10 Older-Generation AEDs 134
7 Opportunity and Unmet Need 136
7.1 Overview 136
7.2 Unmet Needs 137
7.2.1 Refractory Epilepsy 137
7.2.2 Safety/Side Effect Profiles 137
7.2.3 Curative/Disease-Modifying Agents 138
7.2.4 Predictive Tools and Need for More Directed Treatments 139
7.2.5 Improved Preclinical Models and Clinical Trial Paradigms 139
7.2.6 Treatment Gap 140
7.3 Unmet Needs Gap Analysis 141
7.4 Opportunities 142
7.4.1 Disease-Modifying Agents 142
7.4.2 Improved Preclinical Models and Clinical Trial Paradigms 142
7.4.3 Treatment Gap 142
8 Pipeline Assessment 143
8.1 Overview 143
8.2 Clinical Trial Mapping 143
8.2.1 Clinical Trials by Country 143
8.3 Clinical Trials by Phase and Trial Status 145
8.4 Strategic Pipeline Assessment 146
8.5 Pipeline by Phases of Development 147
8.5.1 Phase III Pipeline 147
8.5.2 Phase III Pipeline – Reformulations/New Delivery Systems 148
8.5.3 Phase IIb Pipeline 148
8.5.4 Phase II Pipeline 149
8.5.5 Phase I Pipeline 149
8.5.6 Preclinical Pipeline 150
8.5.7 Discovery Pipeline 151
8.6 Pipeline by Mechanism of Action 151
8.7 Promising Drugs in Clinical Development 153
8.7.1 Brivaracetam 154
8.7.2 Ganaxolone 157
8.7.3 VX-765 161
9 Current and Future Players 165
9.1 Overview 165
9.2 Trends in Corporate Strategy 168
9.3 Company Profiles 169
9.3.1 UCB 169
9.3.2 Eisai 171
9.3.3 Pfizer 172
9.3.4 GlaxoSmithKline 174
9.3.5 Novartis 175
9.3.6 Abbott 177
9.3.7 Dainippon Sumitomo Pharma 179
10 Market Outlook 181
10.1 Global Markets 181
10.1.1 Forecast 181
10.1.2 Drivers and Barriers – Global Issues 184
10.2 United States 186
10.2.1 Forecast 186
10.2.2 Key Events 189
10.2.3 Drivers and Barriers 189
10.3 France 191
10.3.1 Forecast 191
10.3.2 Key Events 194
10.3.3 Drivers and Barriers 194
10.4 Germany 195
10.4.1 Forecast 195
10.4.2 Key Events 199
10.4.3 Drivers and Barriers 199
10.5 Italy 201
10.5.1 Forecast 201
10.5.2 Key Events 204
10.5.3 Drivers and Barriers 204
10.6 Spain 206
10.6.1 Forecast 206
10.6.2 Key Events 209
10.6.3 Drivers and Barriers 209
10.7 United Kingdom 210
10.7.1 Forecast 210
10.7.2 Key Events 214
10.7.3 Drivers and Barriers 214
10.8 Japan 216
10.8.1 Forecast 216
10.8.2 Key Events 219
10.8.3 Drivers and Barriers 219
10.9 India 221
10.9.1 Forecast 221
10.9.2 Key Events 224
10.9.3 Drivers and Barriers 224
10.10 China 226
10.10.1 Forecast 226
10.10.2 Key Events 229
10.10.3 Drivers and Barriers 229
11 Appendix 231
11.1 Bibliography 231
11.2 Abbreviations 244
11.3 Methodology 247
11.4 Forecasting Methodology 247
11.4.1 Prevalent Epilepsy Patients 247
11.4.2 Percent Drug-Treated Patients 248
11.4.3 Drugs Included in Each Therapeutic Class Based on MOA 248
11.4.4 Launch Dates and Patent and Market Exclusivity Expiry Dates 249
11.4.5 General Pricing Assumptions 251
11.4.6 Individual Drug Assumptions 252
11.4.7 Generic Erosion 266
11.4.8 Pricing of Pipeline Agents 266
11.5 Physicians and Specialists Included in this Study 267
11.6 Primary Research – Prescriber Survey 268
11.7 About the Authors 269
11.7.1 Authors 269
11.7.2 Epidemiologist 270
11.7.3 Global Head of Healthcare 270
11.8 About GlobalData 271
11.9 Contact Us 271
11.10 Disclaimer 271
【レポート販売概要】
■ タイトル:てんかん(癲癇):世界医薬品市場予測及び市場分析■ 英文:PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis
■ 発行日:2013年1月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160308
■ 調査対象地域:グローバル
- 世界の分路リアクトル市場2015The Global Shunt Reactor Industry Report 2015 is a professional and in-depth study on the current state of the Shunt Reactor industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Shunt Reactor market analysis is provided for the international markets including development trends, competitive landscape an …
- Acidity:グローバル臨床試験レビューH1, 2013Acidity Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Acidity Global Clinical Trials Review, H1, 2013" provides data on the Acidity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acidity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conductio …
- アメリカのナースコールシステム市場2016-2020About Nurse Call System Market in the USThe NCS helps a caregiver and a patient to effectively communicate with each other and enhance patient care. In the US, individuals undergoing treatment in specialized healthcare facilities such as in SNFs, ALFs, and ACFs need constant attention and care. Hence, to provide 24/7 care to them, there is a need for a dedicated line of communication between patie …
- マルチプロトコルラベルスイッチング(MPLS)インターネットプロトコル(IP)仮想プライベートネットワーク(VPN)サービスの世界市場分析:サービス別(レイヤ2、レイヤ3)、用途別(自動機、ビデオ会議、音声会議)、セグメント予測、-2020The global MPLS IP VPN services market is expected to reach USD 26.62 billion by 2020. Despite considerably maturing over the last five years, the market is poised for high growth on account of appreciable growth potential exhibited by managed MPLS IP VPN services. Enterprises have increasingly started incorporating MPLS IP VPN services for leveraging benefits such as cost minimization and perform …
- 心臓弁修理及び交換装置の世界市場2019-2023About this market The increasing prevalence of cardiovascular diseases will drive the heart valve repair and replacement devices market growth in the forthcoming years. Disorders including the aortic stenosis, pulmonary stenosis, and a congenital heart defect have led to rising demand for heart valve repair and replacement devices. In addition, factors including tobacco abuse, high cholesterol, bl …
- 動物用成長促進剤および機能向上剤の世界市場:抗生物質、ホルモン、飼料用酵素、プロバイオティクス、プレバイオティクス、有機酸、植物、βアゴニストThe animal growth promoters market is expected to reach USD 9.60 Billion in 2020 from USD 7.56 Billion in 2015, growing at a CAGR of 5%. The global animal growth promoters market is segmented on the basis of product and animal. By product, the market is categorized into antibiotics, hormonal growth promoters, beta agonist growth promoters, feed enzymes, probiotics and prebiotics, organic acids, ph …
- 世界の食品テクスチャ市場Texturizing agents are mainly used for improving the texture of the food material by providing it with creaminess, clarity, thickness, stiffening, viscosity, etc. Although many customers are aware of the importance of flavor in the food product, many of them are unaware of the importance of texture in it. A large number of texturizing agents are available to help bring the texture of foods into th …
- 広告の世界市場:テレビ広告、デジタル広告、印刷広告、OOH広告About Advertisements Advertisements include any paid form of non-personal presentation and promotion of ideas, goods or services by an identified sponsor. It is an effective tool used in business to differentiate goods and services in a meaningful way to connect the consumer with the brand. Technavio’s analysts forecast the global advertising market to grow at a CAGR of 5.80% during the period 201 …
- 世界の白金族元素(Platinum Group Metals)市場動向(2014~2018)TechNavio's analysts forecast the Global Platinum Group Metals market to grow at a CAGR of 4.29 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased use of PGMs in Automotive sector. The Global PGM market has also been witnessing the increasing vehicle production worldwide. However, the supply constraints could pose a challenge to the growth …
- 超薄型ガラスの世界市場予測(~2022年):製造プロセス、厚さ、用途、産業、地域別分析The ultra-thin glass market is projected to grow from USD 9.73 Billion in 2017 to USD 16.99 Billion by 2022, at a CAGR of 11.8% from 2017 to 2022. The growing demand for ultra-thin glass from the consumer electronics segment is expected to drive the ultra-thin glass market. The ultra-thin glass market has been segmented on the basis of manufacturing process, thickness, application, end-use industr …
- 苦情管理ソフトウェアの世界市場:コンポーネント別(ソフトウェア、サービス)、タイプ別(統合、スタンドアロン)、展開別(クラウド、オンプレミス)、業種別(BFSI、小売、政府および公共部門、ITおよびテレコム、ホスピタリティ)Complaint management software is a system that enables end users to receive, reply, and resolve customer complaints by using multichannel capabilities, innovative reporting functionalities, and cross-functional collaboration. Monitoring the frequency of complaints by customers and the respective solutions proposed for those complaints aid managers to understand and further develop the product qual …
- Global Planned Oil and Chemicals Storage Industry, 2013 – Investment Opportunities, Analysis and Forecasts of All Planned Terminals to 2017Global Planned Oil and Chemicals Storage Industry, 2013 - Investment Opportunities, Analysis and Forecasts of All Planned Terminals to 2017 Summary “Global Planned Oil and Chemicals Storage Industry, 2013 - Investment Opportunities, Analysis and Forecasts of All Planned Terminals to 2017”, is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive informatio …
- 世界のクラウド型データベース市場About Cloud-based Database Databases are used to store and manage various forms of data generated by a company. Database services can be provided on-premises or on-demand. On-demand services are known as cloud-based databases, which is gaining increasing acceptance among several organizations. A cloud-based database is suitable for organizations that require immediate access to database services, …
- 鋳造設備の世界市場2016-2020About Foundry Equipment A foundry is a facility where cast metal parts are manufactured. The metal is generally melted in a furnace and then poured into a mold and allowed to solidify in the mold to give the cast part the desired shape. The most commonly processed metals are aluminum and cast iron; other metals, including steel, brass, bronze, zinc, and magnesium are also used in foundries to prod …
- 世界のB型肝炎ワクチン市場(2014-2018)About Hepatitis B Vaccines Hepatitis B is an inflammatory condition that occurs due to infection by hepatitis B virus. Hepatitis B virus is an enveloped virus that belongs to the family of hepadnavirus. It contains a circular genome with partially double-stranded DNA. The virus interferes with the normal functioning of the liver cells. Following the viral infection, the immune system is activated …